نتایج جستجو برای: national companies

تعداد نتایج: 467221  

2008
Alexander Schmidt Boris Otto

In today’s companies, particularly multi-national enterprises acting on a global scale, historically grown systems and application landscapes, as well as processes, lead to significant problems when systems (and even employees) need to communicate with each other, i.e. when entities are exchanged across processes and organizational units. What is needed is a common language and, hence, unambigu...

2012
Qian Tang Leigh L. Linden John S. Quarterman Andrew B. Whinston

Cybersecurity is a national priority in this big data era. Because of the lack of incentives and the existence of negative externality, companies often underinvest in addressing security risks and accidents, despite government and industry recommendations. In the present article, we propose a method that utilizes reputation through information disclosure to motivate companies to behave pro-soci...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2013
Roberto Ippoliti

Clinical research is a specific phase of pharmaceutical industry's production process in which companies test candidate drugs on patients to collect clinical evidence about safety and effectiveness. Information is essential to obtain manufacturing authorization from the national drug agency and, in this way, make profits on the market. Considering this activity, however, the public stakeholder ...

2010
Tobias Veith

This paper considers the impact of European telecom regulation on the value of affected companies. Employing a repeating AR-GARCH model, I compare the effect of three types of regulation which are categorized based on the addressed subject, i.e. cross-market, country-specific and company-specific regulation. While standard event study approaches are a special case of ARGARCH models, the approxi...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه تربیت مدرس - دانشکده مهندسی صنایع 1387

according to webster and wind (1972) and anderson et al (1987), “organizational buying is a complex process and involves many people from different functional areas, multiple goals and potentially conflicting decision criteria. moreover, the customers of today are also more knowledgeable and selective when making their purchasing decisions. since a key to organizational survival is the retentio...

2016
Rober Rowan

The therapy is called EWOT (exercise with oxygen therapy) or multi-step therapy. You’ve read about it in the past, but that’s just the beginning of what will be one of the biggest breakthroughs ever in antiaging medicine in decades, and yet it’s still virtually ignored by the medical establishment. Why? Probably because it doesn’t cost much, so the doctors and drug companies aren’t going to get...

Journal: :The British journal of psychiatry : the journal of mental science 2003
Joanna Moncrieff

BACKGROUND Although there is a consensus that clozapine is more effective than conventional antipsychotic drugs for treatment-resistant schizophrenia, there is great heterogeneity among results of relevant trials. AIMS To re-evaluate the evidence comparing clozapine with conventional antipsychotics and to investigate sources of heterogeneity. METHOD Individual studies were inspected with as...

Journal: :Seton Hall law review 2008
Jacqueline Fox

In the early 1970s, Congress directed the Secretary of Health, Education and Welfare to create a commission for the purpose of ascertaining the important principles that should guide biomedical research that uses human research subjects. The report of this commission was to be published by the Secretary in the Federal Register and, unless the Secretary made any other proposals, it was to become...

Journal: :Acta pharmaceutica 2011
Cameron Gordon

Pharmaceutical production and distribution constitute big business. For the companies the rewards can be substantial. Rates of return on drug company investments tend to be higher than many other manufacturing enterprises. But reward is only one side of the story. There is also the issue of social risk, the focus of this article. Social risk for pharmaceutical production is especially pronounce...

Journal: :The American journal of bioethics : AJOB 2010
Carson Strong

ISSN: 1526-5161 (Print) 1536-0075 (Online) Journal homepage: http://www.tandfonline.com/loi/uajb20 Why Academic Medical Centers Should Ban Drug Company Gifts to Individuals Carson Strong To cite this article: Carson Strong (2010) Why Academic Medical Centers Should Ban Drug Company Gifts to Individuals, The American Journal of Bioethics, 10:1, 13-15 To link to this article: http://dx.doi.org/10...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید